Trehalose 6,6'-dimycolate (cord factor) enhances neovascularization through vascular endothelial growth factor production by neutrophils and macrophages

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 2043-2052

  Sakaguchi, Ikuyo ^a,b   Ikeda, Norikazu ^b   Nakayama, Miki ^b   Kato, Yoshiko ^b   Yano, Ikuya ^a   Kaneda, Kenji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inst Skin Sci Club Cosmetics C   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORD FACTOR; INTERLEUKIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHODOCOCCUS;

ANIMALS; ANTIBODIES; CORD FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; FREUND'S ADJUVANT; GRANULOMA; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; LIPIDS; LYMPHOKINES; MACROPHAGES; MALE; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; RHODOCOCCUS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034019161     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.2043-2052.2000     Document Type: Article

References (38)

1. Appleton, I., A. Tomlinson, P. R. Colville-Nash, and D. A. Willoughby. 1993. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Lab. Investig. 69:405-414.
2. Appleton, I., N. J. Brown, D. Willis, P. R. Colville-Nash, C. Alam, J. R. Brown, and D. A. Willoughby. 1996. The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J. Pathol. 180:90-94.
3. Berse, B., J. A. Hunt, R. J. Diegel, P. Morganelli, K. Yeo, F. Brown, and R. A. Fava. 1999. Hypoxia augments cytokine (transforming growth factor-beta [TGF-β] and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin. Exp. Immunol. 115:176-182.
4. Bloch, H. 1948. The relationship between phagocytic cells and human tubercle bacilli. Am. Rev. Tuberc. 58:662-670.
5. Brown, A. E., T. J. Holzer, and B. R. Anderson. 1987. Capacity of human neutrophils to kill Mycobacterium tuberculosis. J. Infect. Dis. 156:985-989.
6. Clauss, M., M. Gerlach, H. Gerlach, J. Brett, F. Wang, P. C. Familletti, Y.-C. E. Pan, J. V. Olander, D. T. Connolly, and D. Stern. 1990. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172:1535-1545.
7. Connolly, D. T., D. M. Heuvelman, R. Nelson, J. V. Olander, B. L. Eppley, J. J. Delfino, N. R. Siegel, R. M. Leimgruber, and J. Feder. 1989. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Investig. 84:1470-1478.
8. Djeu, J. Y., D. Serbousek, and D. K. Blanchard. 1990. Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 76:1405-1409.
9. Fan, L., and S. Iseki. 1998. Immunohistochemical localization of vascular endothelial growth factor in the endocrine glands of the rat. Arch. Histol. Cytol. 61:17-28.
10. Folkman, J., and H. Brem. 1992. Angiogenesis and inflammation, p. 821-839. In J. I. Gallin, I. M. Goldstein, and R. Snyderman (ed.), Inflammation: basic principles and clinical correlates, 2nd ed. Raven Press, New York, N. Y.
11. Gaudry, M., O. Brégerie, V. Andriew, J. E. Benna, M.-A. Pocidalo, and J. Hakim. 1997. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90:4153-4161.
12. Guillemard, E., M. Geniteau-Legendre, R. Kergot, G. Lemaire, S. Gessani, C. Labarre, and A. M. Quero. 1998. Simultaneous production of IFN-gamma, IFN-alpha/beta and nitric oxide in peritoneal macrophages from TDM-treated mice. J. Biol. Regul. Homeostatic Agents 12:106-111.
13. Jackson, R. J., M. P. Seed, C. H. Kircher, D. A. Willoughby, and J. D. Winkler. 1997. The codependence of angiogenesis and chronic inflammation. FASEB J. 11:457-465.
14. 36-48-mycolic acid-containing glycolipids from Nocardia rubra. Infect. Immun. 54:869-875.
15. Kasahara, K., I. Sato, K. Ogura, H. Takeuchi, K. Kobayashi, and M. Adachi. 1998. Expression of chemokines and induction of rapid cell death in human blood neutrophils by Mycobacterium tuberculosis. J. Infect. Dis. 178:127-137.
16. Keck, P. J., S. D. Hauser, G. Krivi, K. Sanzo, T. Warren, J. Feder, and D. T. Connolly. 1989. Vascular permeability factor and endothelial cell mitogen related to PDGF. Science 246:1309-1312.
17. Kimura, M., J. Suzuki, and K. Amemiya. 1985. Mouse granuloma pouch induced by Freund's complete adjuvant with croton oil. J. Pharmacobio-Dyn. 8:393-400.
18. Kobayashi, S., K. Inaba, I. Kimura, and M. Kimura. 1998. Inhibitory effects of tetrandrine on angiogenesis in adjuvant-induced chronic inflammation and tube formation of vascular endothelial cells. Biol. Pharm. Bull. 21:346-349.
19. Kozlowska, U., U. Blume-Peytave, V. Kodelja, C. Sommer, S. Goerdt, S. Jablonska, and C. E. Orfanos. 1998. Vascular endothelial growth factor expression induced by proinflammatory cytokines (interleukin 1 alpha, beta) in cells of the human pilosebaceous unit. Dermatology 196:89-92.
20. 2 release by mouse peritoneal macrophages. FEBS Lett. 149:233-239.
21. Lord, P. C., L. M. G. Wilmoth, S. B. Mizel, and C. E. McCall. 1991. Expression of interleukin 1a and b genes by human blood polymorphonuclear leukocytes. J. Clin. Investig. 87:1312-1321.
22. Maruyama, K., Y. Mori, S. Murasawa, H. Masaki, N. Takahashi, Y. Tsutsumi, Y. Moriguchi, Y. Shibazaki, Y. Tanaka, M. Shibuya, M. Inada, H. Matsubara, and T. Iwasaka. 1999. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. J. Mol. Cell. Cardiol. 31:607-617.
23. Matsunaga, I., S. Oka, and I. Yano. 1990. Mycoloyl glycolipids stimulate macrophages to release a chemotactic factor. FEMS Microbiol. Lett. 67:49-54.
24. McLaren, J., A. Prentice, D. S. Charnock-Jones, S. A. Millican, K. H. Muller, A. M. Sharkey, and S. K. Smith. 1996. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Investig. 98:482-489.
25. Natsuhara, Y., S. Oka, K. Kaneda, Y. Kato, and I. Yano. 1990. Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships. Cancer Immunol. Immunother. 31:99-106.
26. Nomura, M., S. Yamaguchi, S. Harada, Y. Hayashi, T. Yamashita, J. Yamashita, and H. Yamamoto. 1995. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 270:28316-28324.
27. Orbach-Arbouys, S., J.-P. Tenu, and J.-F. Petit. 1983. Enhancement of in vitro and in vivo antitumor activity by cord factor (6-6′-dimycolate of trehalose) administered suspended in saline. Int. Arch. Allergy Appl. Immunol. 71:67-73.
28. Oswald, I. P., C. M. Dozois, J.-F. Petit, and G. Lemaire. 1997. Interleukin-12 synthesis is a required step in trehalose dimycolate-induced activation of mouse peritoneal macrophages. Infect. Immun. 65:1364-1369.
29. Parant, M., F. Parant, L. Chedid, J. C. Drapier, J. F. Petit, J. Wietzerbin, and E. Lederer. 1977. Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6′-trehalose dimycolate). J. Infect. Dis. 135:771- 777.
30. Taichman, N. S., S. Young, A. T. Cruchley, P. Taylor, and E. Paleolog. 1997. Human neutrophils secrete vascular endothelial growth factor. J. Leukoc. Biol. 62:397-400.
31. Tiku, K., M. L. Tiku, and J. L. Skosey. 1986. Interleukin-1 production by human polymorphonuclear neutrophils. J. Immunol. 136:3677-3685.
32. Vermeulen, M. W., and M. J. Fenton. 1996. Immunopathology of tuberculosis, p. 231-266. In R. L. Kradin and B. W. S. Robinson (ed.), Immunopathology of lung disease. Butterworth-Heinemann, Boston, Mass.
33. Watt, S. M., A. W. Burgess, and D. Metcarf. 1979. Isolation and surface labeling of murine polymorphonuclear neutrophils. J. Cell Physiol. 100:1-22.
34. Webb, N. J. A., C. R. Myers, C. J. Watson, M. J. Bottomley, and P. E. C. Brenchley. 1998. Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 10:254-257.
35. Yano, I., I. Tomiyasu, S. Kitabatake, and K. Kaneda. 1984. Granuloma-forming activity of mycolic acid-containing glycolipids in Nocardia and related taxa. Acta Leprol. 2:341-349.
36. Yano, I., S. Oka, Y. Natsuhara, Y. Kato, I. Tomiyasu, and K. Kaneda. 1988. Molecular structure and immunopharmacological activities of the new glycolipids containing mycolic acids in actinomycetales, p. 469-477. In Y. Okami, T. Beppu, and H. Ogawara (ed.), Biology of actinomycetes. Japan Scientific Societies Press, Tokyo, Japan.
37. Yano, I. 1988. Structure analysis and granulomagenic activities of mycolic acid-containing glycolipids in acid-fast bacteria. Kekkaku 63:191-204. (In Japanese with English abstract.)
38. Yoshida, S., M. Ono, T. Shono, H. Izumi, T. Ishibashi, H. Suzuki, and M. Kuwano. 1997. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor alpha-dependent angiogenesis. Mol. Cell. Biol. 17:4015-4023.